-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Wen / Linan " autumn wind is cool weather, grass and trees shake down for frost.
", 2020 has entered the autumn.
At present, the national drug belt procurement has been carried out to the third batch, in September most provinces gave the third batch of collection of the landing implementation time, and more news came out, the future of drug collection will be carried out two batches a year.
Guangxi intends to collect 391 varieties, once again confirmed that within three years 500 varieties will be collected rumors, GPO and the national collection overlay, the auction is expected to be more brutal.
In the national collection, a number of provinces to accelerate the suspension of unestamented drugs hanging network, the selection of drugs with the same variety of drugs over-evaluation of the production enterprises reached more than 3 no longer selected unestamented varieties;
the other side, the state issued a new policy opinion on drug patents, the first generic drug will be a year of market exclusive period, fully encourage domestic high-quality generic pharmaceutical enterprises.
the Chinese Pharmaceutical Society released a new batch of over-repeating drugs, a large number of inferior generic drugs accelerated out of the market.
This month, a new round of medical insurance catalog adjustment of the preliminary examination list announced that 751 drugs through the form of medical insurance review, including 12 included in the new crown pneumonia diagnosis and treatment program varieties, 11 basic drug species, 28 to encourage imitation or clinically urgently needed varieties, 3 national collection of selected varieties.
the survival of the fittest in the medical insurance catalogue, to reserve space for innovative drugs, a number of clinically low-value varieties of good days to the end.
This month's heavyweight focus is also: high-value consumables collection start, crown stents for the first varieties; Jiangsu Province to relax western medicine can not open Chinese medicine requirements; the pharmaceutical industry credit "black list" system to determine; Shandong Province with the volume of procurement of 40 varieties list published; Beijing transferred 224 kinds of non-state health insurance drugs ...